My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Shilchar Technologies standalone net profit rises 55.14% in the September 2016 quarter
Oct 27,2016

Net profit of Shilchar Technologies rose 55.14% to Rs 3.77 crore in the quarter ended September 2016 as against Rs 2.43 crore during the previous quarter ended September 2015. Sales rose 12.90% to Rs 27.30 crore in the quarter ended September 2016 as against Rs 24.18 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales27.3024.18 13 OPM %19.5214.56 - PBDT6.084.06 50 PBT5.713.72 53 NP3.772.43 55

Powered by Capital Market - Live News

Mishtann Foods reports standalone net loss of Rs 0.35 crore in the September 2016 quarter
Oct 27,2016

Net loss of Mishtann Foods reported to Rs 0.35 crore in the quarter ended September 2016 as against net profit of Rs 0.65 crore during the previous quarter ended September 2015. Sales rose 350.00% to Rs 78.66 crore in the quarter ended September 2016 as against Rs 17.48 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales78.6617.48 350 OPM %2.343.72 - PBDT1.240.65 91 PBT0.310.65 -52 NP-0.350.65 PL

Powered by Capital Market - Live News

Ashirwad Steels & Industries standalone net profit declines 67.57% in the September 2016 quarter
Oct 27,2016

Net profit of Ashirwad Steels & Industries declined 67.57% to Rs 0.12 crore in the quarter ended September 2016 as against Rs 0.37 crore during the previous quarter ended September 2015. There were no Sales reported in the quarter ended September 2016 and during the previous quarter ended September 2015.

Powered by Capital Market - Live News

Bliss GVS Pharma standalone net profit declines 16.97% in the September 2016 quarter
Oct 27,2016

Net profit of Bliss GVS Pharma declined 16.97% to Rs 20.06 crore in the quarter ended September 2016 as against Rs 24.16 crore during the previous quarter ended September 2015. Sales declined 4.02% to Rs 88.96 crore in the quarter ended September 2016 as against Rs 92.69 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales88.9692.69 -4 OPM %36.4232.85 - PBDT31.7534.65 -8 PBT30.3033.07 -8 NP20.0624.16 -17

Powered by Capital Market - Live News

Aruna Hotels reports standalone net loss of Rs 0.34 crore in the September 2016 quarter
Oct 27,2016

Net Loss of Aruna Hotels reported to Rs 0.34 crore in the quarter ended September 2016 as against net loss of Rs 0.30 crore during the previous quarter ended September 2015. There were no Sales reported in the quarter ended September 2016 and during the previous quarter ended September 2015.

Powered by Capital Market - Live News

Bliss GVS Pharma consolidated net profit declines 40.76% in the September 2016 quarter
Oct 27,2016

Net profit of Bliss GVS Pharma declined 40.76% to Rs 13.65 crore in the quarter ended September 2016 as against Rs 23.04 crore during the previous quarter ended September 2015. Sales declined 8.89% to Rs 160.34 crore in the quarter ended September 2016 as against Rs 175.99 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales160.34175.99 -9 OPM %26.5624.83 - PBDT40.4846.69 -13 PBT34.8540.78 -15 NP13.6523.04 -41

Powered by Capital Market - Live News

Lakshmi Machine Works tumbles after weak Q2 results
Oct 27,2016

The result was announced after market hours yesterday, 26 October 2016.

Meanwhile, the BSE Sensex was down 118.97 points, or 0.43%, to 27,717.54.

On BSE, so far 4,443 shares were traded in the counter, compared with average daily volume of 7,118 shares in the past one quarter. The stock hit a high of Rs 4,420 and a low of Rs 4,200 so far during the day. The stock hit a record high of Rs 4,698.50 on 6 October 2016. The stock hit a 52-week low of Rs 3,050 on 26 February 2016. The stock had outperformed the market over the past 30 days till 26 October 2016, rising 4.03% compared with 1.37% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 22.52% as against Sensexs 1.32% decline.

The mid-cap company has equity capital of Rs 11.27 crore. Face value per share is Rs 10.

In a separate announcement after market hours yesterday, 26 October 2016, Lakshmi Machine Works announced that its board of directors has approved the buyback of 3.11 lakh equity shares, or 2.76% equity, of the company at Rs 4,450 per share, aggregating to an amount of Rs 138.39 crore.

Lakshmi Machine Works manufacturers entire range of textile spinning machinery from blow room to ring spinning.

Powered by Capital Market - Live News

Smartlink Network spurts after strong Q2 outcome
Oct 27,2016

The announcement was made after market hours yesterday, 26 October 2016.

Meanwhile, the BSE Sensex was down 114.08 points, or 0.41%, to 27,722.43

On BSE, so far 61,000 shares were traded in the counter, compared with an average volume of 8,924 shares in the past one quarter. The stock hit a high of Rs 108.30 and a low of Rs 99.90 so far during the day. The stock hit a 52-week high of Rs 111.70 on 4 December 2015. The stock hit a 52-week low of Rs 69.50 on 17 February 2016. The stock had outperformed the market over the past 30 days till 26 October 2016, rising 11.58% compared with 1.37% decline in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 6.43% as against Sensexs 1.32% decline.

The small-cap company has an equity capital of Rs 6 crore. Face value per share is Rs 2.

Smartlink Network Systems is one of Indias leading networking company. Pioneer in the field of active networking, it offers an integrated value proposition from design and development to sales and marketing, and service and support.

Powered by Capital Market - Live News

Maharashtra Scooters announces resignation of director
Oct 27,2016

Maharashtra Scooters announced that Charu Desai, a Woman Director, has tendered resignation as an Independent Director of the Company, effective 27 October 2016.

Powered by Capital Market - Live News

Sun Pharma gains after announcing acquisition of Ocular Technologies, Sarl.
Oct 27,2016

The announcement was made after market hours yesterday, 26 October 2016.

Meanwhile, the BSE Sensex was down 85.40 points, or 0.31%, to 27,749.23

On BSE, so far 53,000 shares were traded in the counter, compared with average daily volume of 2.76 lakh shares in the past one quarter. The stock hit a high of Rs 749.70 and a low of Rs 737.55 so far during the day. The stock hit a 52-week high of Rs 909.90 on 27 October 2015. The stock hit a 52-week low of Rs 706.40 on 24 November 2015. The stock had underperformed the market over the past 30 days till 26 October 2016, falling 4.02% compared with 1.37% decline in the Sensex. The scrip had also underperformed the market in past one quarter, sliding 10.23% as against Sensexs 1.32% decline.

The large-cap company has equity capital of Rs 240.68 crore. Face value per share is Re 1.

Sun Pharmaceutical Industries (Sun Pharma) announced the execution of definitive agreements by its wholly owned subsidiary for the acquisition of 100% of Ocular Technologies, Sarl (OTS), a portfolio company of Auven Therapeutics (Auven), an international private equity company focused on accelerated development of breakthrough therapeutic drugs. OTS owns exclusive, worldwide rights to Seciera (cyclosporine A, 0.09% ophthalmic solution). Sun Pharma will pay Auven $40 million upfront, plus contingent development milestones and sales milestones as well as tiered royalty on sales of Seciera as consideration for this acquisition.

Seciera is currently in a Phase-3 confirmatory clinical trial for the treatment of Dry Eye Disease, an inflammatory ocular disease affecting approximately 16 million people in the United States alone. Seciera is a patented, novel, proprietary formulation of cyclosporine A 0.09%. It is a clear, preservative-free, aqueous solution. In a completed Phase 2b/3 clinical trial in 455 patients, Seciera demonstrated a rapid onset of action and was well tolerated by the study population. Based on the published data in literature, the efficacy and safety endpoints in these trials compared favorably to other formulations of cyclosporine A.

The transaction is subject to approval of the US Federal Trade Commission as required under the Hart-ScottRodino Act and other closing conditions, and is expected to be completed by end of 2016, Sun Pharma said.

Separately, Sun Pharma announced before market hours today, 27 October 2016 that its wholly owned subsidiary has launched in US, the Authorized Generic (AG) versions for all strengths of Olmesartan Medoxomil tablets - therapeutic equivalent of Daiichi Sankyo Inc.s Benicar (olmesartan medoxomil) tablets; Olmesartan Medoxomil-Hydrochlorothiazide tablets - therapeutic equivalent of Daiichi Sankyo Inc.s Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) tablets; Amlodipine Besylate-Olmesartan Medoxomil tablets - therapeutic equivalent of Daiichi Sankyo Inc.s Azor (amlodipine and olmesartan medoxomil) tablets; and Amlodipine Besylate-Hydrochlorothiazide-Olmesartan Medoxomil tablets - therapeutic equivalent of Daiichi Sankyo Inc.s Tribenzor (olmesartan medoxomil, amlodipine, hydrochlorothiazide) tablets.

The launch is pursuant to a distribution and supply agreement between Sun Pharmas wholly owned subsidiary and Daiichi Sankyo Inc., which grants the Sun Pharma subsidiary, exclusive rights to distribute these tablets in the US for a pre-determined period. Benicar, Benicar HCT, Azor and Tribenzor recorded US sales of approximately $2.5 billion for the 12 months ending 31 August 2016, as per IMS Health.

Sun Pharma announces its Q2 results on 10 November 2016. The companys consolidated net profit surged 265.8% to Rs 2033.71 crore on 22.7% growth in net sales to Rs 8006.68 crore in Q1 June 2016 over Q1 June 2015.

Sun Pharmaceutical Industries is the worlds fifth largest specialty generic pharmaceutical company and Indias top pharmaceutical company.

Powered by Capital Market - Live News

Board of LGB Forge accepts resignation of director
Oct 27,2016

The Board of Directors of LGB Forge at their meeting held on 22 October 2016 noted the resignation of Rajiv Parthasarathy as Director of the Company.

Powered by Capital Market - Live News

E-Auction of the Second Batch of Private FM Radio Phase III Channels Commences
Oct 27,2016

E-Auction of the Second Batch of Private FM Radio Phase III Channels commenced today. During the day, four rounds of bidding took place. 266 FM Channels in 92 cities comprising 227 channels in 69 fresh cities and 39 unsold channels from 23 cities of batch I of Ph-III have been put on auction in the second batch. At the close of first day of bidding, 58 channels in 42 cities became Provisionally Winning Channels with cumulative provisional winning price of around Rs.182 Crore against their aggregate reserve price of about Rs.179.2 Crore.

The auction began today. Total 14 bidders were allowed to participate in the auction. The ongoing auction is a Simultaneous Multiple Round Ascending (SMRA) e-auction which is being conducted on line. States of Uttarakhand and Nagaland and Border Area Towns of Poonch Mokukchung, Leh, Kathua, Kargil, Bhaderwa to have Private FM Channels for the first time.

Powered by Capital Market - Live News

Quick Heal Technologies to hold board meeting
Oct 27,2016

Quick Heal Technologies will hold a meeting of the Board of Directors of the Company on 11 November 2016 to consider and approve standalone unaudited financial results of the Company for the quarter and half year ended September 30, 2016.

Powered by Capital Market - Live News

Kalpa Commercial to hold board meeting
Oct 27,2016

Kalpa Commercial will hold a meeting of the Board of Directors of the Company on 14 November 2016 To consider, Discuss and if thought fit to approve un-audited financial results for quarter ended on September 30, 2016.

Powered by Capital Market - Live News

Vidli Restaurants to hold board meeting
Oct 27,2016

Vidli Restaurants will hold a meeting of the Board of Directors of the Company on 8 November 2016 to consider and approve the Unaudited Financial Results for the half year and period ended on September 30, 2016.

Powered by Capital Market - Live News